Can Placenta Cells Save Severe COVID-19 Patients?
Pluristem CEO Claims Placenta Cell-Therapy Can Rebalance Immune Systems
Pluristem Therapeutics aims to start a multinational clinical trial of PLX cells for treating complications associated with COVID-19 while also helping severe patients recover from the disease under compassionate use programs in the US and Israel.
